Furthermore, studies of the SIV-macaque model, in which the administration of anti-CD8 monoclonal antibodies hinders the decline in viremia, provided strong evidence for the crucial role of CTLs in controlling HIV infection during acute phase [12]. This evidence concerns the gene CD8A and HIV infectious disease.